<img alt="" height="1" width="1" />
Medicare Panel Pans Alzheimer&#39;s Test
MedPage Today
BALTIMORE -- A Medicare advisory panel expressed little support Wednesday for the idea that an imaging technology for the beta-amyloid protein tied to Alzheimer&#39;s disease changes health outcomes. Using a scale of 1 for "low confidence" and 5 for "high ...
CMS panel says evidence lacking for
Panel Says Limited Evidence on Lilly Drug for TestNASDAQ
Medicare Panel Says Alzheimer&#39;s Brain Scans May Not HelpBloomberg
WHTC -PhysBizTech
all 13 news articles &raquo;